Daan Gene Secures Registration Certificate for Chlamydia pneumoniae and Mycoplasma pneumoniae Nucleic Acid Detection Kit

Medical Devices & Diagnostics

Daan Gene Secures Registration Certificate for Respiratory Pathogen Nucleic Acid Detection Kit

The in vitro diagnostic product targets two common causes of community-acquired pneumonia

Daan Gene Co., Ltd. (达安基因), a Chinese in vitro diagnostics company, has obtained a registration certificate for its Chlamydia pneumoniae and Mycoplasma pneumoniae Nucleic Acid Detection Kit, according to a company announcement.

The registration certificate marks a key regulatory milestone, signaling that the product has cleared the compliance threshold required for commercialization in China's medical device market. For in vitro diagnostic products, registration approval from regulatory authorities is a prerequisite before a kit can be marketed and sold to hospitals, clinics, and testing laboratories.

The detection kit targets two pathogens — Chlamydia pneumoniae and Mycoplasma pneumoniae — both of which are common causes of community-acquired pneumonia. These atypical bacteria are responsible for a significant share of respiratory infections, particularly in children and young adults. Rapid and accurate nucleic acid-based identification of these pathogens can help clinicians prescribe targeted antibiotic therapy and avoid unnecessary use of broad-spectrum drugs.

The approval adds to Daan Gene's portfolio of molecular diagnostic products and reflects the company's continued push to expand its pipeline of nucleic acid testing solutions. Registration certificate progress also signals the pace at which a company is converting its R&D output into commercially viable products — a metric closely watched by investors in the diagnostics sector.

The timing of the approval may also carry competitive implications. The respiratory diagnostics segment in China has drawn increasing attention from both domestic and international players, and the speed at which companies bring new assays to market can shape the competitive landscape in this subsector.

Source: Daan Gene company announcement, via East Money